What do GAD-7 scores mean?

Scores of 0–4 indicate minimal anxiety, 5–9 mild, 10–14 moderate, and 15–21 severe anxiety. A score of 10 or above is the recommended cutoff for identifying clinically significant anxiety that warrants further evaluation and possible treatment.

The GAD-7 (Generalized Anxiety Disorder 7-item scale) is a validated screening questionnaire developed by Drs. Spitzer, Kroenke, Williams, and Löwe in 2006. It measures anxiety severity based on 7 symptoms rated for frequency over the past 2 weeks.

Can the GAD-7 diagnose anxiety?

No. The GAD-7 is a screening tool, not a diagnostic instrument. A high score suggests likely anxiety and the need for clinical evaluation, but formal diagnosis requires a comprehensive assessment by a qualified clinician, including clinical interview and exclusion of medical causes.

How accurate is the GAD-7?

At a cutoff of 10, the GAD-7 has sensitivity of 89% and specificity of 82% for generalized anxiety disorder. It has excellent internal consistency (Cronbach's alpha = 0.92) and good test-retest reliability (ICC = 0.83).

Is the GAD-7 only for generalized anxiety disorder?

While developed for GAD, the GAD-7 has reasonable sensitivity for other anxiety disorders: panic disorder (74%), social anxiety disorder (72%), and PTSD (66%). It serves as a useful general anxiety screener, though disorder-specific instruments are more precise for those conditions.

What is a clinically significant change in GAD-7?

A change of 5 or more points is generally considered clinically meaningful. A 50% reduction from baseline is often used to define 'treatment response,' and a final score below 5 typically indicates remission.

How often should I take the GAD-7?

For general screening: annually or when symptoms arise. For treatment monitoring: every 2–4 weeks after starting or changing anxiety treatment. Tracking scores over time is one of the GAD-7's primary clinical uses.

Is the GAD-7 free to use?

Yes. The GAD-7 is in the public domain and can be used without permission or cost. It was developed with an educational grant from Pfizer but is freely available for clinical and research use.

What's the difference between GAD-7 and PHQ-9?

The GAD-7 screens for anxiety disorders; the PHQ-9 screens for depression. They are often administered together because anxiety and depression frequently co-occur. Both use similar formats (symptom frequency over 2 weeks) and scoring approaches.

Can anxiety cause physical symptoms?

Yes. Anxiety commonly causes physical symptoms including rapid heartbeat, sweating, trembling, shortness of breath, chest tightness, nausea, dizziness, and muscle tension. These are real physiological responses to anxiety, not 'just in your head.'

Should I see a doctor if I score 10 or higher?

A score of 10+ warrants evaluation by a healthcare provider. This doesn't necessarily mean you have a disorder or need medication, but it indicates symptoms significant enough to benefit from professional assessment and discussion of treatment options.

What treatments are available for anxiety?

Evidence-based treatments include cognitive-behavioral therapy (CBT), which is highly effective, and medications such as SSRIs, SNRIs, and buspirone. Lifestyle modifications (exercise, sleep hygiene, stress reduction) also help. Treatment choice depends on severity, preferences, and individual factors.

Is GAD-7 valid for teenagers?

The GAD-7 has been validated in adolescents and performs reasonably well, though some studies suggest modified cutoffs may be appropriate. For children under 12, other instruments (SCARED, Spence Children's Anxiety Scale) are preferred.

Does the GAD-7 work in different languages?

Yes. The GAD-7 has been translated and validated in numerous languages. Validated translations maintain psychometric properties similar to the original English version. Use officially validated translations rather than informal ones.

How does GAD-7 relate to DSM-5 criteria?

The GAD-7 items align with core GAD symptoms (excessive anxiety, difficulty controlling worry, restlessness, fatigue, concentration problems, irritability, muscle tension, sleep disturbance) but DSM-5 also requires symptoms for 6+ months and functional impairment — which require clinical assessment beyond the questionnaire.

Online Medical Tools — GAD-7

Printed on 8/14/2026

For informational purposes only. This is not medical advice.

Mental Health

GAD-7

The GAD-7 (Generalized Anxiety Disorder 7-item scale) is the most widely used screening tool for anxiety disorders. Answer 7 questions about symptoms over the past 2 weeks to receive your severity score (0–21) with clinical interpretation. The GAD-7 screens for generalized anxiety and has good sensitivity for panic disorder, social anxiety, and PTSD. For a quick 2-question anxiety screen, use GAD-2. Depression and anxiety frequently co-occur — assess with PHQ-9. Screen for PTSD with PCL-5. For alcohol use disorder screening, see AUDIT.

Formula: Total score = sum of all 7 items (each 0-3). Range 0-21.

1. Feeling nervous, anxious, or on edge

2. Not being able to stop or control worrying

3. Worrying too much about different things

4. Trouble relaxing

5. Being so restless that it is hard to sit still

6. Becoming easily annoyed or irritable

7. Feeling afraid, as if something awful might happen

Save your results with a free account

Keep a history of calculations, favorite tools, and access your dashboard anytime.

Create free account Sign in

How It Works

Answer 7 questions

Rate how often you've been bothered by each symptom over the past 2 weeks: not at all (0), several days (1), more than half the days (2), or nearly every day (3).

Get your severity score

Your responses are summed to produce a score from 0–21. The score maps to four severity categories: minimal, mild, moderate, or severe anxiety.

Understand your results

Review what your score means and recommended next steps. Scores of 10+ indicate clinically significant anxiety that warrants professional evaluation.

Who Uses the GAD-7

Primary Care Screening

Family physicians & internists

GAD-7 is often administered alongside PHQ-9 to screen for both anxiety and depression. Takes under 2 minutes and provides actionable severity stratification.

Treatment Monitoring

Psychiatrists & therapists

Serial GAD-7 scores track treatment response to medication or therapy. A 5-point change is clinically meaningful; 50% reduction indicates treatment response.

Clinical Research

Researchers

GAD-7 is a standard outcome measure in anxiety treatment trials. Its brevity and validation enable large-scale studies and cross-study comparisons.

Workplace Wellness

Employee assistance programs

Anxiety significantly impacts workplace productivity. EAPs use GAD-7 to identify employees who may benefit from counseling or stress management programs.

Student Mental Health

University counseling centers

Anxiety disorders are the most common mental health issue among college students. GAD-7 helps counseling centers triage and track student outcomes.

Personal Self-Check

Individuals self-monitoring

If you're wondering whether your worry and nervousness might be an anxiety disorder, GAD-7 provides an evidence-based starting point before seeking professional help.

Pro Tips

Answer based on the past 2 weeks

The GAD-7 asks about the last 2 weeks specifically. Don't include how you felt months ago or during a particularly stressful event that has passed.

Consider taking PHQ-9 too

Anxiety and depression frequently co-occur (up to 60% comorbidity). If you score elevated on GAD-7, also complete the PHQ-9 to give your provider a complete picture.

A score of 10 is the clinical threshold

While any score can prompt evaluation, 10+ is the standard cutoff for 'clinically significant' anxiety. At this threshold, sensitivity is 89% and specificity is 82% for GAD.

Track changes over time

Taking the GAD-7 periodically (monthly or after treatment changes) reveals trends. A 5-point improvement is clinically meaningful; look for patterns over weeks to months.

Functional impairment matters too

A score of 8 with severe work impairment may warrant treatment sooner than a score of 12 with preserved function. Consider how anxiety affects your daily life beyond the number.

This screens for more than GAD

While developed for generalized anxiety, GAD-7 has reasonable sensitivity for panic disorder (74%), social anxiety (72%), and PTSD (66%). A high score suggests any anxiety disorder.

Physical symptoms of anxiety are real

Anxiety causes genuine physical symptoms (racing heart, sweating, muscle tension, GI distress). If you're experiencing these, the GAD-7 can help clarify whether anxiety is the cause.

Rule out medical causes

Hyperthyroidism, caffeine excess, stimulant medications, and withdrawal states can mimic anxiety. If you score high, a medical workup may be appropriate.

Be honest about your experience

The tool is only useful if you answer truthfully. There's no 'passing' or 'failing' — the goal is to understand your symptoms and get appropriate help if needed.

Low score doesn't mean you're fine

GAD-7 may miss specific phobias, OCD, or atypical anxiety presentations. If you're struggling but scored low, trust your experience and seek evaluation anyway.

Common Questions About Your Results

Stress and anxiety overlap but differ. Stress is typically tied to a specific external situation and resolves when the situation ends. Anxiety involves excessive worry that persists, may not have a clear trigger, and often includes physical symptoms (restlessness, muscle tension, difficulty concentrating). A high GAD-7 score suggests your stress response may have crossed into clinical anxiety territory.

Evidence-Based Methodology

The GAD-7 was developed and validated by Spitzer, Kroenke, Williams, and Löwe (2006). At a cutoff of 10, sensitivity is 89% and specificity is 82% for GAD. It has been cited over 15,000 times and is the most widely used anxiety screening instrument in clinical practice and research worldwide.

Clinical Content Trust

Last reviewed:: April 21, 2026
Guideline version:: General evidence framework v2026.04
Source set version:: Primary-source set v1

How to Interpret Your Result

Your GAD-7 score falls into one of four severity categories: minimal (0–4), mild (5–9), moderate (10–14), or severe (15–21). A score of 10 or above is the standard threshold for identifying clinically significant anxiety that warrants further evaluation and potential treatment.

Scores in the mild range (5–9) may still be clinically relevant depending on functional impairment — a patient scoring 8 who is unable to work or maintain relationships may need intervention sooner than a patient scoring 12 with preserved function. The score is best used as one data point alongside clinical assessment of how anxiety affects daily life.

When to Use This Tool

The GAD-7 is appropriate for initial anxiety screening in primary care, mental health, and research settings. It is recommended as a first-line screening tool by multiple clinical guidelines and is frequently paired with the PHQ-9 to simultaneously screen for both anxiety and depression, which commonly co-occur.

It is also useful for monitoring treatment response — repeating the GAD-7 at regular intervals (every 2–4 weeks) after initiating therapy (pharmacological or psychotherapeutic) provides an objective measure of symptom change. A decrease of 5 or more points is generally considered clinically meaningful improvement.

Limitations

The GAD-7 was developed and validated primarily for generalized anxiety disorder. While it has reasonable sensitivity for other anxiety disorders (panic disorder, social anxiety, PTSD), it may miss cases or underestimate severity for these conditions. Disorder-specific scales (e.g., PCL-5 for PTSD, SPIN for social anxiety) are more appropriate when a specific diagnosis is suspected.

Like all self-report instruments, the GAD-7 is subject to recall bias, response bias, and cultural differences in how anxiety is expressed and reported. Somatic presentations of anxiety (e.g., chest tightness, gastrointestinal symptoms) may not be fully captured by the questionnaire items.

The GAD-7 does not distinguish between anxiety disorders and anxiety symptoms caused by medical conditions (hyperthyroidism, stimulant use, withdrawal states) or other psychiatric conditions. A clinical interview is needed for accurate diagnosis.

Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.

Changelog

April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.

Related Tools